The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why COSM Stock surged +11.45% Today — RQD Quant Desk Flash
Cosmos Health Inc. (COSM) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±12.5% realized swing band)
FRED Regime × Technicals: 18% of 52W Range • RSI-14 at 51.5 (NEUTRAL RANGE)
Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a COSM Turnaround Squeeze
While COSM currently carries a cautious 31/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.30) and Max Pain ($0.29) forces dealer call-delta covering toward $0.87.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why COSM Stock surged +11.45% Today — RQD Quant Desk Flash
Cosmos Health Inc. (COSM) surged +11.45% to $0.28, trading at 18% of its 52-week range ($0.16 – $0.83). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 18% of its 52-week range ($0.16 – $0.83) with RSI-14 at 51.5 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.28 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 12.1% gross margin and $0 annual free cash flow.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Qatar surges, bucking Gulf market slide on Iran war concerns Reuters
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
German ministers pledge tough action after rioters damage stores in Frankfurt Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring COSM)
- ✓Walkthrough of COSM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
COSM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +19.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on COSM today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for COSM. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (COSM)
1. Head-to-Head Health Care Peer Comparison (COSM vs. ESYN, ZSTK, MEDS, HKPD)
Industry: Other Pharmaceuticals (10 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Cosmos Health Inc. (COSM) ranks #933 by composite RQD confidence (31/100, grade E) and #811 by equity capitalization ($27.9M). Within this direct 5-issuer industry benchmark cohort, COSM leads on earnings valuation at N/A trailing P/E, while COSM leads on capital efficiency and profitability with -35.0% ROIC and 12.1% gross margin. HKPD currently holds the highest overall quantitative score in the immediate peer group at 51/100 (D) compared with COSM at 31/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| COSM
ACTIVE
Cosmos Health Inc. | E | 31/100 | — | 12.1% | -35.0% | +11.45% | $27.9M | Benchmark Subject |
| ESYN EnerSyn Global Inc. | D- | 41/100 | — | 53.0% | -35.0% | +3.10% | $54.4M | /esyn-vs-cosm → |
| ZSTK ZeroStack Corp. | E | 31/100 | — | 4.6% | -35.0% | -0.34% | $63.9M | /zstk-vs-cosm → |
| MEDS DataMeds AI Inc. | E | 30/100 | — | -27.5% | -35.0% | -7.73% | $9.8M | /meds-vs-cosm → |
| HKPD Cellyan Biotechnology Co. Ltd (Class A) | D | 51/100 | — | — | — | +0.46% | $5.4M | /hkpd-vs-cosm → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001474167In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cosmos Health Inc. (COSM) reported GAAP revenue of $65.3M (+19.9% vs. FY2024 revenue of $54.4M , and +22.3% cumulative change since FY2023) , GAAP net income of -$19.1M, operating cash flow of -$8.4M, and free cash flow of -$8.5M (-4.5% YoY). On the balance sheet, COSM closed FY2025 with $65.5M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $65.3M | -$19.1M | -$8.4M | -$8.5M | $65.5M | — |
| FY2024 (FY) | 2024-12-31 | $54.4M | -$16.2M | -$7.7M | -$8.1M | $54.3M | — |
| FY2023 (FY) | 2023-12-31 | $53.4M | -$18.5M | -$15.6M | -$15.6M | — | — |
3. COSM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs COSM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Cosmos Health Inc. (NASDAQ: COSM) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $0.28 (+11.45% 1D, market cap $27.9M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, COSM ranks #933 in composite RQD confidence.
How does COSM compare to ESYN and ZSTK in the Health Care sector?
Within the Health Care sector (Other Pharmaceuticals), COSM carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of 12.1%, and ROIC of -35.0%. By comparison, ESYN (EnerSyn Global Inc.) holds a D- grade (41/100 RQD, P/E N/A, ROIC -35.0%, cap $54.4M) and ZSTK (ZeroStack Corp.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M). Among the 5-stock peer group, COSM leads on earnings multiple (N/A) while COSM leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for COSM?
Per COSM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001474167), Cosmos Health Inc. generated $65.3M in revenue (+19.9% YoY), -$19.1M in net income, and -$8.5M in free cash flow against $65.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is COSM trading relative to its 50-day, 200-day, and 52-week technical levels?
COSM last traded at $0.28 (+11.45% on volume of 1,853,480 shares), positioning the stock -6.67% below its 50-day simple moving average ($0.30) and -9.68% below its 200-day simple moving average ($0.31). Across its 52-week range of $0.16 to $0.83, COSM sits at the 17.9% percentile with a 14-day RSI of 51.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.32).
COSM Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is COSM stock moving today?
Why COSM Stock surged +11.45% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.